Cargando…

The Role of Acupoint Application of Herbal Medicine for Asthma: Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials

BACKGROUND: Acupoint application of herbal medicine (AAHM) has been widely used in China. At present, there is no systematic review of AAHM versus placebo in the treatment of asthma. This systematic review aims to assess the efficacy of AAHM for asthma. METHODS: Searches were conducted in five Engli...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zhenhu, Zheng, Yanchan, Chen, Yaoxin, He, Bing, Wu, Lei, Lin, Lin, Xu, Yinji, Chen, Yuanbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477641/
https://www.ncbi.nlm.nih.gov/pubmed/36118096
http://dx.doi.org/10.1155/2022/5589433
_version_ 1784790407385710592
author Wu, Zhenhu
Zheng, Yanchan
Chen, Yaoxin
He, Bing
Wu, Lei
Lin, Lin
Xu, Yinji
Chen, Yuanbin
author_facet Wu, Zhenhu
Zheng, Yanchan
Chen, Yaoxin
He, Bing
Wu, Lei
Lin, Lin
Xu, Yinji
Chen, Yuanbin
author_sort Wu, Zhenhu
collection PubMed
description BACKGROUND: Acupoint application of herbal medicine (AAHM) has been widely used in China. At present, there is no systematic review of AAHM versus placebo in the treatment of asthma. This systematic review aims to assess the efficacy of AAHM for asthma. METHODS: Searches were conducted in five English databases and four Chinese databases from their inceptions until December 2020. Randomized double-blind placebo-controlled trials were screened, and included studies evaluated routine pharmacotherapy (RP) plus AAHM versus RP plus placebo or AAHM versus placebo. The Cochrane risk of bias tool and Grading of Recommendations Assessment, Development and Evaluation (GRADE) were performed to evaluate the methodological quality and quality of evidence separately. RESULTS: Sixteen studies involving 1,730 participants were included in this review. Compared with placebo plus RP, participants receiving long-term AAHM plus RP showed improvement in asthma quality of life questionnaire (AQLQ) with moderate-quality evidence (MD 6.53 points, 95% CI 2.70 to 10.36). Low-quality evidence indicated that AAHM plus RP was associated with improved FEV(1) (%) compared with placebo plus RP, whether long- or short-term use (MD 11.80%, 95% CI 2.84 to 20.76; MD 10.57%, 95% CI 8.40 to 12.74; respectively). Moderate-quality evidence showed that participants receiving short-term AAHM were associated with a higher AQLQ score (MD 6.57 points, 95% CI 3.76 to 9.38) and a lower frequency of acute exacerbations (MD –1.84, 95% CI –2.32 to –1.36) compared with placebo. Low-quality evidence also indicated that AAHM was associated with improved FEV(1) (L) compared with placebo, whether long- or short-term use (MD 0.35 litres, 95% CI 0.03 to 0.67; MD 0.66 litres, 95% CI 0.59 to 0.73; respectively). CONCLUSIONS: Moderate-quality evidence is promising that AAHM can improve the quality of life and reduce acute exacerbations in patients with asthma. AAHM also shows a positive role in improving lung function, but the evidence is so indefinite due to low quality.
format Online
Article
Text
id pubmed-9477641
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-94776412022-09-16 The Role of Acupoint Application of Herbal Medicine for Asthma: Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials Wu, Zhenhu Zheng, Yanchan Chen, Yaoxin He, Bing Wu, Lei Lin, Lin Xu, Yinji Chen, Yuanbin Evid Based Complement Alternat Med Review Article BACKGROUND: Acupoint application of herbal medicine (AAHM) has been widely used in China. At present, there is no systematic review of AAHM versus placebo in the treatment of asthma. This systematic review aims to assess the efficacy of AAHM for asthma. METHODS: Searches were conducted in five English databases and four Chinese databases from their inceptions until December 2020. Randomized double-blind placebo-controlled trials were screened, and included studies evaluated routine pharmacotherapy (RP) plus AAHM versus RP plus placebo or AAHM versus placebo. The Cochrane risk of bias tool and Grading of Recommendations Assessment, Development and Evaluation (GRADE) were performed to evaluate the methodological quality and quality of evidence separately. RESULTS: Sixteen studies involving 1,730 participants were included in this review. Compared with placebo plus RP, participants receiving long-term AAHM plus RP showed improvement in asthma quality of life questionnaire (AQLQ) with moderate-quality evidence (MD 6.53 points, 95% CI 2.70 to 10.36). Low-quality evidence indicated that AAHM plus RP was associated with improved FEV(1) (%) compared with placebo plus RP, whether long- or short-term use (MD 11.80%, 95% CI 2.84 to 20.76; MD 10.57%, 95% CI 8.40 to 12.74; respectively). Moderate-quality evidence showed that participants receiving short-term AAHM were associated with a higher AQLQ score (MD 6.57 points, 95% CI 3.76 to 9.38) and a lower frequency of acute exacerbations (MD –1.84, 95% CI –2.32 to –1.36) compared with placebo. Low-quality evidence also indicated that AAHM was associated with improved FEV(1) (L) compared with placebo, whether long- or short-term use (MD 0.35 litres, 95% CI 0.03 to 0.67; MD 0.66 litres, 95% CI 0.59 to 0.73; respectively). CONCLUSIONS: Moderate-quality evidence is promising that AAHM can improve the quality of life and reduce acute exacerbations in patients with asthma. AAHM also shows a positive role in improving lung function, but the evidence is so indefinite due to low quality. Hindawi 2022-01-31 /pmc/articles/PMC9477641/ /pubmed/36118096 http://dx.doi.org/10.1155/2022/5589433 Text en Copyright © 2022 Zhenhu Wu et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Wu, Zhenhu
Zheng, Yanchan
Chen, Yaoxin
He, Bing
Wu, Lei
Lin, Lin
Xu, Yinji
Chen, Yuanbin
The Role of Acupoint Application of Herbal Medicine for Asthma: Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials
title The Role of Acupoint Application of Herbal Medicine for Asthma: Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials
title_full The Role of Acupoint Application of Herbal Medicine for Asthma: Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials
title_fullStr The Role of Acupoint Application of Herbal Medicine for Asthma: Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials
title_full_unstemmed The Role of Acupoint Application of Herbal Medicine for Asthma: Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials
title_short The Role of Acupoint Application of Herbal Medicine for Asthma: Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials
title_sort role of acupoint application of herbal medicine for asthma: meta-analysis of randomized double-blind placebo-controlled trials
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477641/
https://www.ncbi.nlm.nih.gov/pubmed/36118096
http://dx.doi.org/10.1155/2022/5589433
work_keys_str_mv AT wuzhenhu theroleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials
AT zhengyanchan theroleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials
AT chenyaoxin theroleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials
AT hebing theroleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials
AT wulei theroleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials
AT linlin theroleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials
AT xuyinji theroleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials
AT chenyuanbin theroleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials
AT wuzhenhu roleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials
AT zhengyanchan roleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials
AT chenyaoxin roleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials
AT hebing roleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials
AT wulei roleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials
AT linlin roleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials
AT xuyinji roleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials
AT chenyuanbin roleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials